Colgate-Palmolive vs Ambev
Global oral care and household products leader vs Leading Latin American brewer with extensive distribution network. Which is the better buy for your portfolio in June 2026? Plain-English answer below.
Colgate-Palmolive is an American consumer staples institution with dominant toothpaste and personal care brands distributed across more than 200 countries and a pricing power track record built over more than a century, while Ambev is the undisputed dominant beer and soft drinks company across Latin America, with volume scale across Brazil and neighboring markets that rivals simply can't match cost-effectively. Colgate-Palmolive vs Ambev puts two powerful consumer goods franchises in direct comparison, both earning high returns on capital and both navigating meaningful emerging market currency exposure in their international businesses. Readers find a detailed examination of organic volume versus pricing growth, dividend payout sustainability, cost structure flexibility, and which franchise delivers more reliable earnings through a global consumption slowdown.
Colgate-Palmolive is an American consumer staples institution with dominant toothpaste and personal care brands distributed across more than 200 countries and a pricing power track record built over m...
Why It’s Moving
Colgate-Palmolive faces fresh analyst pressure as margin worries keep the stock under strain.
- TD Cowen cut Colgate-Palmolive to Hold from Buy, citing heightened inflationary pressure and weaker room for margin expansion.
- Argus also downgraded the stock to Hold, highlighting margin pressure and a minimal growth outlook that could limit upside.
- Stifel reduced its rating to Hold and trimmed its price target, reinforcing the view that the shares are being capped by valuation concerns and slower earnings momentum.
Ambev S.A. Shares Shift as Investors React to Initial 2025 Earnings and Regional Segment Performance
- The company's initial 2025 earnings report revealed varied operational results across its four key segments, with Brazil and Central America showing distinct performance trends compared to Latin America South and Canada.
- Analysts are closely monitoring how the company's core activities—production, distribution, and sale of beer and other beverages—are adapting to regional economic shifts in Brazil and Latin America.
- Market attention is focused on the company's governance and audit frameworks as documented in recent SEC filings, signaling potential adjustments in strategic oversight alongside its financial performance.
Colgate-Palmolive faces fresh analyst pressure as margin worries keep the stock under strain.
- TD Cowen cut Colgate-Palmolive to Hold from Buy, citing heightened inflationary pressure and weaker room for margin expansion.
- Argus also downgraded the stock to Hold, highlighting margin pressure and a minimal growth outlook that could limit upside.
- Stifel reduced its rating to Hold and trimmed its price target, reinforcing the view that the shares are being capped by valuation concerns and slower earnings momentum.
Ambev S.A. Shares Shift as Investors React to Initial 2025 Earnings and Regional Segment Performance
- The company's initial 2025 earnings report revealed varied operational results across its four key segments, with Brazil and Central America showing distinct performance trends compared to Latin America South and Canada.
- Analysts are closely monitoring how the company's core activities—production, distribution, and sale of beer and other beverages—are adapting to regional economic shifts in Brazil and Latin America.
- Market attention is focused on the company's governance and audit frameworks as documented in recent SEC filings, signaling potential adjustments in strategic oversight alongside its financial performance.
Investment Analysis
Pros
- Colgate-Palmolive reported revenue growth of 3.31% in 2024, reaching $20.10 billion, indicating steady top-line expansion.
- The company has strong brand diversification across oral care, personal care, home care, and pet nutrition segments, supporting market resilience.
- Colgate-Palmolive maintains a solid dividend yield around 2.7%, offering a consistent income stream for shareholders.
Considerations
- Colgate-Palmolive's stock has shown limited price appreciation over the past year, which may be unattractive for growth-focused investors.
- The company has a relatively high debt-to-equity ratio, which raises concerns about its financial leverage and risk exposure.
- Its price-to-earnings (P/E) ratio near 22 suggests potential overvaluation compared to peers, limiting upside from current levels.
Ambev
ABEV
Pros
- Ambev is a leading beverage company in Latin America with strong market share in beer and soft drinks, benefiting from regional brand loyalty and scale.
- The company has demonstrated growth potential driven by premium product launches and expansion in emerging markets with rising consumer incomes.
- Ambev maintains efficient production and distribution infrastructure, supporting operational margins despite commodity price volatility.
Considerations
- Ambev faces currency volatility risks due to significant exposure to emerging markets with fluctuating exchange rates impacting earnings.
- The company's performance is sensitive to regulation and taxation changes in the alcoholic beverages sector, which can constrain profitability.
- Economic slowdown or reduced consumer spending in key Latin American markets poses demand risks given Ambev's market concentration.
Colgate-Palmolive (CL) Next Earnings Date
Colgate-Palmolive’s next earnings date for CL is expected to be July 31, 2026, before the market opens. The report should cover Q2 2026 results. This timing is consistent with the company’s usual late-July earnings pattern.
Ambev (ABEV) Next Earnings Date
The next earnings date for Ambev S.A. (ABEV) is projected to be Thursday, July 30, 2026, based on the company's consistent historical reporting schedule. This upcoming report is expected to cover the financial results for the second quarter of 2026 (Q2 2026). While the company has not yet formally confirmed the exact date, July 30 aligns with their typical mid-year announcement pattern for this quarter. Investors should monitor official company filings for any potential adjustments to this timeline.
Colgate-Palmolive (CL) Next Earnings Date
Colgate-Palmolive’s next earnings date for CL is expected to be July 31, 2026, before the market opens. The report should cover Q2 2026 results. This timing is consistent with the company’s usual late-July earnings pattern.
Ambev (ABEV) Next Earnings Date
The next earnings date for Ambev S.A. (ABEV) is projected to be Thursday, July 30, 2026, based on the company's consistent historical reporting schedule. This upcoming report is expected to cover the financial results for the second quarter of 2026 (Q2 2026). While the company has not yet formally confirmed the exact date, July 30 aligns with their typical mid-year announcement pattern for this quarter. Investors should monitor official company filings for any potential adjustments to this timeline.
Buy CL or ABEV in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
